The patient is taking center stage. And life sciences companies need to react. They need to move from being a supplier of a single drug to creating individual patient-specific treatments. This requires them to develop a digital strategy along the entire value chain. This is one of the key findings of the KPMG study "Digitalization in life sciences - Integrating the patient pathway into the technology ecosystem".